- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Beryl Drugs covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (63), financial health (85), director (90) and company-foundation signals.
- Operating for 32+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2025.
- Positive net worth.
- 9 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Beryl Drugs
Beryl Drugs is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L02423MP1993PLC007840). Business overview includes Pharma (Drug Formulation & Development), incorporated on August 24, 1993 (33+ years old), headquartered in Indore, Madhya Pradesh, India. The company is currently Active with Active Compliant compliance status.
- Location 29, Neer Nagar, Mayank Water Park Road, Bicholi, Indore, Madhya Pradesh - 452016
- Website beryldrugs.com
Financial Performance of Beryl Drugs
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Beryl Drugs (9)
Charges of Beryl Drugs
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 27 Jun 2024 |
1.75 cr | Closed |
|
Others
Creation Date: 16 May 2024 |
45.00 Lakh | Closed |
|
Others
Creation Date: 20 Mar 2023 |
1.15 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
